Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zev A Binder

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Clinical Neurology and Neurosurgery|February 4, 2011
Glioblastoma multiforme in the Muir-Torre syndromeZev A Binder, Michael W Johnson, Avadhut Joshi, et al.
Journal for Immunotherapy of Cancer|December 2, 2024
Novel tri-specific T-cell engager targeting IL-13Rα2 and EGFRvIII provides long-term survival in heterogeneous GBM challenge and promotes antitumor cytotoxicity with patient immune cellsDaniel H Park, Pratik S Bhojnagarwala, Kevin Liaw, et al.
Cell Reports|June 8, 2022
Single-cell RNA-seq-based proteogenomics identifies glioblastoma-specific transposable elements encoding HLA-I-presented peptidesPierre-Emmanuel Bonté, Yago A Arribas, Antonela Merlotti, et al.
Veterinary Pathology|January 10, 2024
Humanization with CD34-positive hematopoietic stem cells in NOG-EXL mice results in improved long-term survival and less severe myeloid cell hyperactivation phenotype relative to NSG-SGM3 miceElinor Willis, Jillian Verrelle, Esha Banerjee, et al.
Frontiers in Immunology|May 23, 2022
PD1 Expression in EGFRvIII-Directed CAR T Cell Infusion Product for Glioblastoma Is Associated with Clinical ResponseOliver Y Tang, Lifeng Tian, Todd Yoder, et al.
Journal of Neurosurgery|January 31, 2012
Establishment and characterization of a primary human chordoma xenograft modelI-Mei Siu, Vafi Salmasi, Brent A Orr, et al.
Frontiers in Oncology|September 27, 2021
High-Affinity Chimeric Antigen Receptor With Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic IsoformsRadhika Thokala, Zev A Binder, Yibo Yin, et al.
Journal of Neuro-Oncology|November 18, 2018
Histopathologic quantification of viable tumor versus treatment effect in surgically resected recurrent glioblastomaStephen J Bagley, Robert D Schwab, Ernest Nelson, et al.
Head & Neck|October 30, 2014
Intraoperative hypertensive crisis due to a catecholamine-secreting esthesioneuroblastomaVafi Salmasi, Adam Schiavi, Zev A Binder, et al.
Neuro-Oncology|September 20, 2022
EGFR, the Lazarus target for precision oncology in glioblastomaBenjamin Lin, Julia Ziebro, Erin Smithberger, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Clinical Neurology and Neurosurgery|February 4, 2011
Glioblastoma multiforme in the Muir-Torre syndromeZev A Binder, Michael W Johnson, Avadhut Joshi, et al.
Journal for Immunotherapy of Cancer|December 2, 2024
Novel tri-specific T-cell engager targeting IL-13Rα2 and EGFRvIII provides long-term survival in heterogeneous GBM challenge and promotes antitumor cytotoxicity with patient immune cellsDaniel H Park, Pratik S Bhojnagarwala, Kevin Liaw, et al.
Cell Reports|June 8, 2022
Single-cell RNA-seq-based proteogenomics identifies glioblastoma-specific transposable elements encoding HLA-I-presented peptidesPierre-Emmanuel Bonté, Yago A Arribas, Antonela Merlotti, et al.
Veterinary Pathology|January 10, 2024
Humanization with CD34-positive hematopoietic stem cells in NOG-EXL mice results in improved long-term survival and less severe myeloid cell hyperactivation phenotype relative to NSG-SGM3 miceElinor Willis, Jillian Verrelle, Esha Banerjee, et al.
Frontiers in Immunology|May 23, 2022
PD1 Expression in EGFRvIII-Directed CAR T Cell Infusion Product for Glioblastoma Is Associated with Clinical ResponseOliver Y Tang, Lifeng Tian, Todd Yoder, et al.
Journal of Neurosurgery|January 31, 2012
Establishment and characterization of a primary human chordoma xenograft modelI-Mei Siu, Vafi Salmasi, Brent A Orr, et al.
Frontiers in Oncology|September 27, 2021
High-Affinity Chimeric Antigen Receptor With Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic IsoformsRadhika Thokala, Zev A Binder, Yibo Yin, et al.
Journal of Neuro-Oncology|November 18, 2018
Histopathologic quantification of viable tumor versus treatment effect in surgically resected recurrent glioblastomaStephen J Bagley, Robert D Schwab, Ernest Nelson, et al.
Head & Neck|October 30, 2014
Intraoperative hypertensive crisis due to a catecholamine-secreting esthesioneuroblastomaVafi Salmasi, Adam Schiavi, Zev A Binder, et al.
Neuro-Oncology|September 20, 2022
EGFR, the Lazarus target for precision oncology in glioblastomaBenjamin Lin, Julia Ziebro, Erin Smithberger, et al.
Pageof 7